Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Myron Levin

Concepts (855)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpes Zoster
106
2025
319
17.650
 Why?
Herpes Zoster Vaccine
66
2025
154
16.200
 Why?
Herpesvirus 3, Human
88
2026
343
12.030
 Why?
Chickenpox
25
2026
84
5.740
 Why?
Antibodies, Viral
68
2026
674
5.110
 Why?
Chickenpox Vaccine
28
2026
76
4.580
 Why?
Immunity, Cellular
36
2024
274
4.430
 Why?
Influenza Vaccines
18
2024
534
2.790
 Why?
HIV Infections
40
2026
3195
2.660
 Why?
Vaccines, Attenuated
32
2024
129
2.590
 Why?
Neuralgia, Postherpetic
18
2019
40
2.320
 Why?
Immunocompromised Host
13
2019
202
2.300
 Why?
Antiviral Agents
28
2022
769
2.180
 Why?
Adjuvants, Immunologic
17
2023
244
2.020
 Why?
Simplexvirus
24
2016
82
2.010
 Why?
Acyclovir
27
2016
98
1.950
 Why?
Vaccination
34
2026
1428
1.890
 Why?
Herpes Simplex
17
2016
99
1.790
 Why?
DNA, Viral
24
2018
356
1.660
 Why?
Trypanosoma cruzi
13
2007
39
1.610
 Why?
Papillomavirus Vaccines
13
2018
296
1.480
 Why?
Viral Envelope Proteins
6
2021
98
1.400
 Why?
Herpesvirus 1, Human
10
2016
84
1.370
 Why?
Vaccines, Synthetic
16
2025
137
1.340
 Why?
Influenza, Human
13
2024
624
1.330
 Why?
Immunogenicity, Vaccine
5
2026
37
1.330
 Why?
Pregnancy Complications, Infectious
16
2020
440
1.320
 Why?
Humans
297
2026
145783
1.310
 Why?
T-Lymphocytes
20
2019
1998
1.310
 Why?
Antiretroviral Therapy, Highly Active
13
2017
279
1.270
 Why?
Immunologic Memory
12
2019
368
1.220
 Why?
Aged
92
2024
26217
1.220
 Why?
Aged, 80 and over
47
2022
8347
1.200
 Why?
Immunization, Secondary
13
2017
92
1.200
 Why?
CD4-Positive T-Lymphocytes
13
2023
1146
1.150
 Why?
Papillomavirus Infections
9
2018
344
1.100
 Why?
Antibodies, Protozoan
5
2007
41
1.100
 Why?
Middle Aged
102
2026
36309
1.020
 Why?
Ribosomal Proteins
6
2006
93
1.010
 Why?
Female
159
2026
79045
0.990
 Why?
Chagas Disease
8
2007
42
0.980
 Why?
Double-Blind Method
33
2026
2064
0.980
 Why?
Pneumococcal Vaccines
4
2026
129
0.970
 Why?
Protozoan Proteins
6
2006
90
0.950
 Why?
Male
141
2026
73011
0.920
 Why?
T-Lymphocyte Subsets
6
2019
420
0.920
 Why?
Vaccines, Inactivated
9
2023
70
0.860
 Why?
Viral Vaccines
12
2014
107
0.850
 Why?
Receptors, Adrenergic, beta-1
4
2007
24
0.850
 Why?
Antibodies, Neutralizing
13
2023
340
0.840
 Why?
Herpesvirus 2, Human
6
2014
27
0.820
 Why?
Incidence
22
2023
2934
0.810
 Why?
Interferon-gamma
18
2022
784
0.780
 Why?
Virus Latency
4
2014
90
0.780
 Why?
Immune Sera
4
2020
77
0.770
 Why?
Respiratory Syncytial Virus, Human
3
2019
81
0.760
 Why?
CD8-Positive T-Lymphocytes
5
2018
923
0.750
 Why?
B-Lymphocytes
9
2021
872
0.750
 Why?
Enzyme-Linked Immunosorbent Assay
22
2021
849
0.740
 Why?
Injections, Intramuscular
5
2022
146
0.740
 Why?
Influenza A Virus, H1N1 Subtype
6
2017
159
0.710
 Why?
Age Factors
17
2021
3346
0.700
 Why?
Respiratory Syncytial Virus Vaccines
2
2019
39
0.690
 Why?
Rotavirus Infections
3
2017
37
0.680
 Why?
Drug Resistance, Viral
7
2009
126
0.680
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
2017
13
0.680
 Why?
Influenza B virus
6
2012
47
0.650
 Why?
Child, Preschool
44
2026
11868
0.640
 Why?
Anti-Retroviral Agents
5
2018
251
0.630
 Why?
Vaccination Coverage
2
2018
102
0.620
 Why?
Rotavirus Vaccines
2
2017
39
0.620
 Why?
Adenovirus Infections, Human
4
2015
15
0.610
 Why?
Infant
32
2026
10091
0.610
 Why?
Infectious Disease Transmission, Vertical
7
2020
194
0.600
 Why?
Down Syndrome
2
2023
525
0.590
 Why?
Child
61
2026
22740
0.590
 Why?
Adult
77
2026
40881
0.580
 Why?
Polymerase Chain Reaction
13
2019
1043
0.580
 Why?
Th1 Cells
3
2018
139
0.580
 Why?
Clinical Trials as Topic
15
2019
1062
0.570
 Why?
Insurance Claim Review
1
2019
83
0.560
 Why?
Adolescent
55
2026
22577
0.560
 Why?
HIV
4
2010
251
0.560
 Why?
AIDS-Related Opportunistic Infections
4
2015
130
0.550
 Why?
Alphapapillomavirus
4
2016
35
0.550
 Why?
Influenza A Virus, H3N2 Subtype
4
2017
50
0.550
 Why?
Cytomegalovirus Infections
4
2015
206
0.550
 Why?
CD4 Lymphocyte Count
14
2017
280
0.540
 Why?
Antibody Formation
8
2023
288
0.540
 Why?
Immunoglobulin G
11
2021
892
0.530
 Why?
Dose-Response Relationship, Immunologic
3
2016
76
0.520
 Why?
Virus Shedding
6
2017
49
0.520
 Why?
Pneumonia
1
2023
636
0.510
 Why?
Health Expenditures
1
2019
194
0.510
 Why?
Interleukin-2
7
2022
440
0.500
 Why?
Herpesviridae Infections
4
2015
148
0.500
 Why?
Cytosine
3
2015
49
0.490
 Why?
Pain
6
2022
791
0.490
 Why?
Anti-HIV Agents
6
2015
912
0.480
 Why?
Infant, Premature
5
2020
620
0.480
 Why?
Antigens, Viral
21
2017
182
0.470
 Why?
Organophosphonates
2
2015
95
0.470
 Why?
Cytomegalovirus
7
2006
168
0.460
 Why?
Injections, Subcutaneous
1
2016
170
0.460
 Why?
Guanine
14
2006
85
0.450
 Why?
Enzyme-Linked Immunospot Assay
4
2018
37
0.450
 Why?
Follow-Up Studies
22
2019
5428
0.450
 Why?
Refrigeration
2
2018
11
0.440
 Why?
Immunization
5
2014
375
0.440
 Why?
Polyomavirus Infections
1
2015
30
0.430
 Why?
Health Care Costs
1
2018
425
0.430
 Why?
Immunity, Humoral
3
2021
118
0.430
 Why?
Uterine Cervical Neoplasms
5
2016
268
0.420
 Why?
Viral Load
12
2018
526
0.420
 Why?
Skin Diseases
1
2016
152
0.420
 Why?
Oropharynx
1
2014
46
0.420
 Why?
Herpes Genitalis
7
2014
17
0.420
 Why?
Blood
1
2014
107
0.410
 Why?
Drug Combinations
4
2023
396
0.400
 Why?
Infant, Newborn
28
2023
6465
0.390
 Why?
Monocytes
8
2025
539
0.390
 Why?
Vaccines
3
2018
389
0.390
 Why?
Herpes Labialis
3
2013
9
0.380
 Why?
T-Lymphocytes, Regulatory
1
2016
411
0.380
 Why?
Placebos
8
2017
193
0.370
 Why?
Trigeminal Ganglion
2
2003
27
0.370
 Why?
Time Factors
20
2021
7134
0.370
 Why?
Post-Exposure Prophylaxis
2
2023
13
0.350
 Why?
Aging
10
2017
1973
0.350
 Why?
Sensory Receptor Cells
1
2012
98
0.350
 Why?
United States
18
2026
16126
0.350
 Why?
RNA, Viral
21
2018
693
0.340
 Why?
Young Adult
24
2023
14254
0.340
 Why?
Retrospective Studies
16
2023
17330
0.340
 Why?
Communicable Diseases
1
2014
166
0.340
 Why?
Randomized Controlled Trials as Topic
8
2021
1752
0.340
 Why?
Human papillomavirus 18
5
2018
12
0.310
 Why?
Quality of Life
7
2021
3211
0.310
 Why?
Human papillomavirus 16
5
2018
27
0.310
 Why?
Glycoproteins
2
2023
354
0.310
 Why?
Pregnancy
20
2020
7216
0.300
 Why?
Databases, Factual
4
2019
1491
0.300
 Why?
Animals
42
2021
38102
0.300
 Why?
Induced Pluripotent Stem Cells
1
2012
273
0.300
 Why?
Chagas Cardiomyopathy
4
2007
27
0.300
 Why?
Poverty
1
2013
529
0.290
 Why?
Cost-Benefit Analysis
4
2024
644
0.290
 Why?
Frail Elderly
2
2020
136
0.290
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2009
20
0.290
 Why?
Vaccines, Subunit
5
2021
53
0.290
 Why?
Risk Factors
20
2023
10919
0.280
 Why?
Treatment Outcome
19
2016
11794
0.270
 Why?
Epitopes
4
2005
473
0.270
 Why?
Varicella Zoster Virus Infection
2
2018
29
0.260
 Why?
Meningitis, Viral
3
1997
20
0.260
 Why?
Activities of Daily Living
3
2021
444
0.260
 Why?
Meningitis
1
2008
80
0.260
 Why?
Hemagglutination Inhibition Tests
7
2017
38
0.260
 Why?
Seasons
3
2023
538
0.250
 Why?
Research Design
2
2013
1139
0.250
 Why?
Autoantibodies
3
2007
1509
0.250
 Why?
Cytokines
7
2018
2069
0.250
 Why?
Viral Plaque Assay
8
2012
29
0.250
 Why?
Antibodies, Monoclonal
3
2023
1505
0.250
 Why?
Cells, Cultured
19
2012
4151
0.250
 Why?
Recurrence
14
2019
1139
0.250
 Why?
Viremia
5
2018
160
0.250
 Why?
Prospective Studies
25
2019
8078
0.240
 Why?
Neurons
6
2003
1652
0.240
 Why?
Immunocompetence
4
2019
46
0.230
 Why?
Respiratory Syncytial Virus Infections
3
2017
139
0.230
 Why?
Nucleic Acid Hybridization
11
2006
187
0.230
 Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
261
0.220
 Why?
Neoplasms
3
2016
2913
0.220
 Why?
Virus Replication
12
2018
521
0.220
 Why?
Cell Count
2
2005
319
0.210
 Why?
Cross Reactions
6
2014
130
0.210
 Why?
Nucleosides
1
2004
25
0.210
 Why?
Intestines
2
2018
354
0.210
 Why?
Sleep Wake Disorders
4
2013
314
0.210
 Why?
Severity of Illness Index
14
2015
2933
0.210
 Why?
Vaccine Potency
3
2019
6
0.210
 Why?
Transforming Growth Factor beta1
1
2025
177
0.210
 Why?
Viral Proteins
5
2018
350
0.210
 Why?
Molecular Sequence Data
9
2006
2883
0.210
 Why?
Influenza A virus
5
2012
119
0.210
 Why?
Health Resources
2
2019
130
0.210
 Why?
Nonlinear Dynamics
1
2005
93
0.210
 Why?
Phosphoproteins
1
2006
337
0.200
 Why?
Interferons
9
1982
186
0.200
 Why?
Herpesvirus 4, Human
3
2014
172
0.200
 Why?
Cholecalciferol
1
2024
61
0.200
 Why?
Genetic Variation
1
2008
977
0.200
 Why?
Neuralgia
4
2010
140
0.200
 Why?
Immunoassay
2
2017
109
0.190
 Why?
Antibody Affinity
2
2021
60
0.190
 Why?
Enterovirus Infections
5
1995
173
0.190
 Why?
Long-Term Care
1
2024
118
0.190
 Why?
Cricetinae
6
2007
305
0.190
 Why?
Transforming Growth Factor beta
1
2025
474
0.190
 Why?
Encephalitis
2
1995
142
0.190
 Why?
Ganglia, Spinal
2
1993
88
0.180
 Why?
Developing Countries
2
2016
317
0.180
 Why?
CHO Cells
3
2007
169
0.180
 Why?
Lymphocyte Activation
13
2015
1133
0.180
 Why?
Pain Measurement
8
2019
562
0.180
 Why?
Papillomaviridae
3
2011
116
0.180
 Why?
Antibodies, Bacterial
4
2026
147
0.180
 Why?
Recombinant Proteins
4
2018
1368
0.180
 Why?
Lymphocytosis
1
2021
12
0.180
 Why?
Virus Activation
4
2010
94
0.180
 Why?
Longitudinal Studies
8
2018
2968
0.170
 Why?
Immunosenescence
1
2021
5
0.170
 Why?
Mice
12
2021
18356
0.170
 Why?
Cell Separation
1
2002
306
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.160
 Why?
Herpes Simplex Virus Vaccines
2
2012
4
0.160
 Why?
Genes, Protozoan
1
2000
13
0.160
 Why?
Virology
1
2001
36
0.160
 Why?
Fluorescent Antibody Technique
6
2016
365
0.160
 Why?
Cell Line
16
2018
2823
0.160
 Why?
Intermediate Filament Proteins
1
2000
57
0.160
 Why?
Case-Control Studies
5
2018
3634
0.160
 Why?
RNA Helicases
1
2000
27
0.160
 Why?
Fetal Diseases
4
1991
194
0.160
 Why?
Amino Acid Sequence
5
2006
2131
0.160
 Why?
Fibroblasts
10
2018
1028
0.160
 Why?
Vitamin D
1
2024
404
0.160
 Why?
Immunoglobulin A
3
2017
214
0.160
 Why?
Terminal Repeat Sequences
1
2000
17
0.160
 Why?
Health Services for the Aged
1
2001
73
0.160
 Why?
Enterovirus
3
1995
83
0.160
 Why?
Short Interspersed Nucleotide Elements
1
2000
12
0.160
 Why?
Feces
3
2017
496
0.160
 Why?
Laboratories
1
2001
110
0.150
 Why?
HIV-1
5
2018
908
0.150
 Why?
Carrier Proteins
2
2001
729
0.150
 Why?
Antidepressive Agents
2
2013
242
0.150
 Why?
Acquired Immunodeficiency Syndrome
2
1993
237
0.150
 Why?
Cohort Studies
10
2022
6033
0.150
 Why?
Retroelements
1
2000
50
0.150
 Why?
Immunoenzyme Techniques
3
2006
200
0.150
 Why?
Epitope Mapping
3
2005
61
0.150
 Why?
Leukocytes, Mononuclear
5
2010
574
0.150
 Why?
Base Sequence
10
2007
2171
0.150
 Why?
Immunization, Passive
4
1994
90
0.150
 Why?
Dietary Supplements
1
2024
584
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2026
992
0.150
 Why?
Myocytes, Cardiac
1
2004
546
0.150
 Why?
Immunization Schedule
3
2016
186
0.150
 Why?
Pneumococcal Infections
2
2013
104
0.150
 Why?
Hemophilia A
2
1993
148
0.140
 Why?
Delivery of Health Care, Integrated
1
2022
303
0.140
 Why?
Myocardium
3
2001
935
0.140
 Why?
Heart Transplantation
2
2007
680
0.140
 Why?
Cholera Toxin
1
2018
29
0.140
 Why?
Autophagosomes
1
2018
20
0.140
 Why?
Liver Transplantation
1
2006
827
0.140
 Why?
Infant, Premature, Diseases
3
1995
113
0.140
 Why?
Microbial Sensitivity Tests
8
2005
365
0.140
 Why?
Lymphocytes
8
1998
376
0.140
 Why?
Age Distribution
3
2016
404
0.140
 Why?
Sex Distribution
3
2016
388
0.140
 Why?
Killer Cells, Natural
2
2025
481
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
79
0.130
 Why?
Drug Therapy, Combination
4
2016
1043
0.130
 Why?
Regression Analysis
2
2019
1001
0.130
 Why?
Immune Evasion
1
2018
61
0.130
 Why?
Viral Fusion Proteins
1
2017
21
0.130
 Why?
Simian virus 40
11
1977
24
0.130
 Why?
Genes, Viral
2
2006
88
0.130
 Why?
Lysosomes
1
2018
131
0.130
 Why?
Multivariate Analysis
2
2018
1547
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
75
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2017
50
0.130
 Why?
Protein Subunits
1
2018
229
0.130
 Why?
Hepatitis B Vaccines
2
2026
43
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Cell Division
5
2003
757
0.130
 Why?
Disease Transmission, Infectious
1
2018
69
0.130
 Why?
Cryopreservation
1
2018
113
0.130
 Why?
Models, Biological
1
2005
1764
0.130
 Why?
Cost of Illness
5
2014
324
0.130
 Why?
Observational Studies as Topic
1
2017
134
0.130
 Why?
Body Mass Index
1
2026
2447
0.130
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
81
0.120
 Why?
Infectious Mononucleosis
2
1991
10
0.120
 Why?
Receptors, Muscarinic
1
1996
20
0.120
 Why?
Receptors, Adrenergic, beta-2
1
1996
36
0.120
 Why?
Africa
1
2017
119
0.120
 Why?
Infusions, Intravenous
2
2016
428
0.120
 Why?
Triatoma
2
2006
7
0.120
 Why?
Foscarnet
3
2003
22
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Depression
3
2013
1559
0.120
 Why?
Comorbidity
3
2019
1662
0.120
 Why?
Latex Fixation Tests
1
1996
4
0.120
 Why?
Erythema
1
2016
28
0.120
 Why?
Lopinavir
1
2016
30
0.120
 Why?
Atazanavir Sulfate
1
2016
42
0.120
 Why?
Insect Vectors
2
2006
39
0.120
 Why?
Ribavirin
2
1994
81
0.120
 Why?
Peptide Fragments
3
2007
697
0.120
 Why?
Autophagy
1
2018
291
0.120
 Why?
Frailty
1
2019
205
0.120
 Why?
HIV Protease Inhibitors
1
2016
69
0.110
 Why?
Ritonavir
1
2016
75
0.110
 Why?
Bone Marrow Transplantation
3
1990
298
0.110
 Why?
Dipeptides
1
2015
56
0.110
 Why?
Lymphocyte Subsets
1
2015
78
0.110
 Why?
Host-Pathogen Interactions
1
2018
361
0.110
 Why?
Chronic Disease
6
2019
1812
0.110
 Why?
Genotype
3
2008
1857
0.110
 Why?
Drug Administration Schedule
3
2026
782
0.110
 Why?
Brain Stem
1
1995
98
0.110
 Why?
BK Virus
1
2015
18
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
266
0.110
 Why?
Data Interpretation, Statistical
3
2019
368
0.110
 Why?
Guatemala
1
2016
343
0.110
 Why?
Hospitalization
2
2023
2461
0.110
 Why?
TOR Serine-Threonine Kinases
1
2018
456
0.110
 Why?
Propylene Glycols
1
2015
28
0.110
 Why?
Hematopoietic Stem Cell Transplantation
2
2015
699
0.110
 Why?
Medication Reconciliation
1
2015
32
0.110
 Why?
Global Health
1
2018
403
0.110
 Why?
Sphingosine
1
2015
47
0.110
 Why?
Reproducibility of Results
5
2013
3418
0.110
 Why?
Transfusion Reaction
1
1995
61
0.110
 Why?
Infant, Newborn, Diseases
1
2016
115
0.110
 Why?
COS Cells
2
2007
177
0.100
 Why?
Species Specificity
3
2006
546
0.100
 Why?
Maus Elberfeld virus
2
1991
5
0.100
 Why?
Survival Rate
3
2016
2094
0.100
 Why?
Respiratory Syncytial Viruses
4
1993
58
0.100
 Why?
Maternal-Fetal Exchange
3
1995
170
0.100
 Why?
Immunity, Mucosal
2
2012
98
0.100
 Why?
Chlamydia trachomatis
2
1991
49
0.100
 Why?
Histocompatibility Antigens Class I
1
1996
202
0.100
 Why?
Hemagglutinins, Viral
1
1994
8
0.100
 Why?
Clinical Trials, Phase III as Topic
3
2021
116
0.100
 Why?
Laryngeal Diseases
1
1994
31
0.100
 Why?
DNA-Directed DNA Polymerase
2
1992
48
0.100
 Why?
Rats
4
2006
5585
0.100
 Why?
Autoantigens
1
1996
427
0.100
 Why?
Lymphoma
1
2015
241
0.100
 Why?
Zidovudine
2
2015
77
0.100
 Why?
Immunoglobulins, Intravenous
5
1995
133
0.100
 Why?
Lamivudine
2
2015
65
0.100
 Why?
Analgesics
3
2010
231
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Needs Assessment
1
2016
403
0.100
 Why?
Placenta
2
1991
787
0.100
 Why?
Cross-Over Studies
2
2013
610
0.100
 Why?
Ethics, Research
1
2013
31
0.100
 Why?
Anti-Inflammatory Agents
3
2013
478
0.100
 Why?
Research Subjects
1
2013
41
0.100
 Why?
Practice Guidelines as Topic
2
2017
1582
0.090
 Why?
Epitopes, T-Lymphocyte
1
2014
174
0.090
 Why?
Mice, Inbred BALB C
3
2006
1261
0.090
 Why?
Health Status
2
2010
835
0.090
 Why?
RNA Probes
2
1991
12
0.090
 Why?
Dose-Response Relationship, Drug
4
2026
2028
0.090
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1996
297
0.090
 Why?
Measles Vaccine
1
2012
19
0.090
 Why?
Gene Expression Regulation, Viral
1
2012
93
0.090
 Why?
Picornaviridae Infections
2
1990
53
0.090
 Why?
Autoimmune Diseases
1
1996
469
0.090
 Why?
Risk Assessment
4
2016
3752
0.090
 Why?
Drug Resistance, Microbial
4
2001
64
0.090
 Why?
Immunosuppressive Agents
3
2015
838
0.090
 Why?
Human papillomavirus 31
1
2011
1
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
Colorado
4
2018
4556
0.090
 Why?
Flow Cytometry
5
2017
1165
0.090
 Why?
Meningitis, Aseptic
1
1991
13
0.090
 Why?
T-Lymphocytes, Cytotoxic
2
2011
177
0.090
 Why?
Indoles
1
2015
507
0.080
 Why?
Linear Models
2
2010
849
0.080
 Why?
Efficiency
1
2012
103
0.080
 Why?
Mutation
5
2009
4090
0.080
 Why?
Chorioamnionitis
1
1991
50
0.080
 Why?
Gastroenteritis
2
1989
63
0.080
 Why?
Cytotoxicity Tests, Immunologic
2
1996
39
0.080
 Why?
Macrophages
3
2005
1507
0.080
 Why?
Insurance, Health
1
2014
311
0.080
 Why?
Neurogenesis
1
2012
157
0.080
 Why?
Neural Stem Cells
1
2012
168
0.080
 Why?
Sequence Alignment
2
2008
362
0.080
 Why?
Drug Design
1
2012
175
0.080
 Why?
Adjuvants, Pharmaceutic
2
2022
15
0.080
 Why?
Epidemiological Monitoring
3
2018
70
0.080
 Why?
Cervix Uteri
1
2010
50
0.080
 Why?
Exanthema
1
2011
86
0.080
 Why?
Sensitivity and Specificity
3
2009
2000
0.080
 Why?
Serum
1
2010
58
0.080
 Why?
Adenoviridae
9
2005
199
0.080
 Why?
Herpesviridae
2
1981
21
0.080
 Why?
Electrocardiography
2
2005
668
0.080
 Why?
Antidepressive Agents, Tricyclic
1
2010
31
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Heart Rate
2
2006
856
0.080
 Why?
Immunoglobulin M
1
1991
265
0.080
 Why?
Antigen-Presenting Cells
5
2010
159
0.080
 Why?
Enterovirus B, Human
2
1988
25
0.080
 Why?
Respiratory Tract Infections
1
1994
396
0.070
 Why?
Dermatomyositis
1
1989
24
0.070
 Why?
Health Services Accessibility
1
2018
1101
0.070
 Why?
Poliovirus
2
2001
73
0.070
 Why?
DNA, Kinetoplast
2
2006
2
0.070
 Why?
Medicaid
1
2014
467
0.070
 Why?
Receptors, Virus
2
2006
95
0.070
 Why?
Placenta Diseases
1
1989
20
0.070
 Why?
DNA Primers
2
2009
505
0.070
 Why?
Protozoan Infections
1
1989
11
0.070
 Why?
Surveys and Questionnaires
7
2021
6085
0.070
 Why?
Drug Stability
1
2009
169
0.070
 Why?
Thymidine Kinase
4
2001
16
0.070
 Why?
Pilot Projects
1
2015
1898
0.070
 Why?
Skin Diseases, Viral
1
2008
6
0.070
 Why?
Oligonucleotide Probes
1
1988
48
0.070
 Why?
Geriatrics
1
2010
95
0.070
 Why?
Gene Expression
2
2006
1478
0.070
 Why?
Immunologic Deficiency Syndromes
2
1986
68
0.070
 Why?
Kinetics
2
2010
1568
0.070
 Why?
Vagina
1
2010
203
0.070
 Why?
Muscles
1
1989
330
0.070
 Why?
Hydrocortisone
1
2010
298
0.070
 Why?
In Vitro Techniques
6
2003
1049
0.070
 Why?
Administration, Intranasal
1
2008
94
0.070
 Why?
Poisson Distribution
2
2005
78
0.070
 Why?
Interferon Type I
1
1989
147
0.070
 Why?
Geriatric Assessment
1
2010
240
0.070
 Why?
Picornaviridae
1
1988
18
0.070
 Why?
Postoperative Complications
2
2000
2977
0.070
 Why?
Lipid A
2
2018
27
0.070
 Why?
Enterocolitis, Pseudomembranous
1
1988
29
0.070
 Why?
Pertussis Vaccine
1
2007
24
0.070
 Why?
Anticonvulsants
1
2010
246
0.070
 Why?
Evidence-Based Practice
1
2010
231
0.070
 Why?
Immunosorbent Techniques
1
2007
18
0.060
 Why?
Quality-Adjusted Life Years
1
2007
125
0.060
 Why?
Data Collection
1
2010
643
0.060
 Why?
Spinal Cord
2
2001
382
0.060
 Why?
Cricetulus
1
2007
118
0.060
 Why?
Receptor, IGF Type 2
1
2006
5
0.060
 Why?
Prevalence
4
2018
2875
0.060
 Why?
Acute Kidney Injury
1
2015
874
0.060
 Why?
Vero Cells
1
2006
83
0.060
 Why?
Inhibitory Concentration 50
1
2006
91
0.060
 Why?
Trypanosomatina
1
2006
1
0.060
 Why?
Opportunistic Infections
3
1993
47
0.060
 Why?
Research
1
2010
431
0.060
 Why?
Immunoglobulin Fragments
1
2006
11
0.060
 Why?
Public Health
1
2012
574
0.060
 Why?
Neutralization Tests
5
2012
76
0.060
 Why?
Animal Diseases
1
2006
9
0.060
 Why?
NIH 3T3 Cells
1
2006
145
0.060
 Why?
Cyclic AMP
1
2007
208
0.060
 Why?
Administration, Topical
4
2013
155
0.060
 Why?
Veterans
1
2018
1642
0.060
 Why?
Trees
1
2006
60
0.060
 Why?
Meningococcal Vaccines
1
2006
57
0.060
 Why?
Immunoglobulin Variable Region
1
2006
80
0.060
 Why?
Random Allocation
6
1992
365
0.060
 Why?
Pregnancy Outcome
1
2010
504
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1969
0.060
 Why?
Kaplan-Meier Estimate
3
2016
971
0.060
 Why?
Hepatitis A Vaccines
1
2026
19
0.060
 Why?
Nasopharyngeal Diseases
1
1985
5
0.060
 Why?
Hybridization, Genetic
9
1974
74
0.060
 Why?
Sequence Analysis, DNA
3
2007
778
0.060
 Why?
Logistic Models
2
2010
2139
0.060
 Why?
Pneumonia, Viral
2
1990
391
0.060
 Why?
Endocytosis
1
2006
168
0.060
 Why?
Motor Activity
1
2010
718
0.060
 Why?
Bone Marrow
2
1984
307
0.060
 Why?
GB virus C
1
2005
1
0.060
 Why?
Flaviviridae Infections
1
2005
2
0.060
 Why?
Uterine Cervical Dysplasia
2
2016
27
0.060
 Why?
Proportional Hazards Models
1
2009
1330
0.060
 Why?
Hepatitis, Viral, Human
1
2005
21
0.060
 Why?
Antineoplastic Agents
2
2016
2219
0.060
 Why?
Hydrogen-Ion Concentration
1
2006
532
0.060
 Why?
Predictive Value of Tests
3
2010
2123
0.060
 Why?
Normal Distribution
1
2005
22
0.050
 Why?
HLA Antigens
3
1987
240
0.050
 Why?
Evaluation Studies as Topic
3
1996
164
0.050
 Why?
Cell Differentiation
1
2012
2050
0.050
 Why?
Conservation of Natural Resources
1
2006
119
0.050
 Why?
Blotting, Western
3
2015
1184
0.050
 Why?
Transfection
1
2007
927
0.050
 Why?
Open Reading Frames
2
2007
130
0.050
 Why?
Organ Transplantation
1
2008
253
0.050
 Why?
Autopsy
2
2001
94
0.050
 Why?
Mammals
1
2006
286
0.050
 Why?
Neurons, Afferent
1
2005
102
0.050
 Why?
Disease Outbreaks
1
1988
419
0.050
 Why?
Risk
3
2016
923
0.050
 Why?
Receptors, Cholinergic
1
2004
41
0.050
 Why?
Macaca radiata
2
2001
15
0.050
 Why?
Cell Culture Techniques
1
2006
375
0.050
 Why?
Cell Adhesion Molecules
1
2005
181
0.050
 Why?
Receptors, Adrenergic, beta
1
2004
58
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2003
60
0.050
 Why?
Sex Factors
2
2003
2110
0.050
 Why?
Mental Health
1
2010
796
0.050
 Why?
Demography
2
2018
282
0.050
 Why?
Abdominal Neoplasms
1
2003
47
0.050
 Why?
Down-Regulation
1
2025
618
0.050
 Why?
Receptors, Cell Surface
1
2005
372
0.050
 Why?
RNA
2
1988
912
0.050
 Why?
2-Aminopurine
2
2007
10
0.050
 Why?
Polymorphism, Single Nucleotide
2
2009
2181
0.050
 Why?
Adaptive Immunity
2
2017
167
0.050
 Why?
Membrane Glycoproteins
1
2005
499
0.050
 Why?
Multicenter Studies as Topic
2
2001
413
0.050
 Why?
Biopsy
2
2000
1082
0.050
 Why?
Pre-Exposure Prophylaxis
1
2026
269
0.050
 Why?
Argentina
3
2006
30
0.050
 Why?
Poliomyelitis
2
2001
35
0.050
 Why?
Dendritic Cells
1
2025
501
0.040
 Why?
Neuroblastoma
1
2003
174
0.040
 Why?
Maltose-Binding Proteins
1
2001
13
0.040
 Why?
Forecasting
3
2010
390
0.040
 Why?
Cell Nucleus
3
1991
588
0.040
 Why?
Hepatitis C
1
2004
256
0.040
 Why?
Glutathione Transferase
1
2001
92
0.040
 Why?
Respirovirus Infections
2
1991
14
0.040
 Why?
Spondylarthropathies
1
2021
5
0.040
 Why?
Poliovirus Vaccine, Oral
1
2001
25
0.040
 Why?
Interspersed Repetitive Sequences
1
2000
5
0.040
 Why?
Peripheral Nerves
1
2001
72
0.040
 Why?
Blotting, Southern
1
2000
85
0.040
 Why?
Expressed Sequence Tags
1
2000
43
0.040
 Why?
Fatal Outcome
1
2001
305
0.040
 Why?
Endocardium
1
2000
31
0.040
 Why?
Alanine
1
2001
169
0.040
 Why?
Mutagenesis
1
2001
194
0.040
 Why?
Cloning, Molecular
1
2001
538
0.040
 Why?
Secondary Prevention
2
2013
251
0.040
 Why?
Phosphorylation
2
2002
1708
0.040
 Why?
Blotting, Northern
1
2000
203
0.040
 Why?
Genome, Viral
1
2002
214
0.040
 Why?
Virion
1
2001
108
0.040
 Why?
Sex Characteristics
2
2017
789
0.040
 Why?
Amino Acid Motifs
1
2000
219
0.040
 Why?
DNA, Protozoan
1
2000
32
0.040
 Why?
Consensus Sequence
1
2000
73
0.040
 Why?
DEAD-box RNA Helicases
1
2000
84
0.040
 Why?
Canada
2
2012
432
0.040
 Why?
Psoriasis
1
2021
115
0.040
 Why?
Immunity, Innate
1
2025
835
0.040
 Why?
Amniotic Fluid
3
1991
79
0.040
 Why?
Transcription, Genetic
5
2000
1454
0.040
 Why?
Chromosome Mapping
1
2000
507
0.040
 Why?
Sequence Homology, Amino Acid
1
2000
387
0.040
 Why?
Autoimmunity
1
2005
933
0.040
 Why?
Enterotoxins
2
1994
89
0.040
 Why?
Sleep
1
2006
889
0.040
 Why?
Recombinant Fusion Proteins
1
2001
666
0.040
 Why?
Rats, Sprague-Dawley
1
2004
2525
0.030
 Why?
Saponins
1
2018
12
0.030
 Why?
Seroconversion
1
2018
48
0.030
 Why?
Saliva
2
2010
249
0.030
 Why?
Hematopoietic Stem Cells
1
1982
435
0.030
 Why?
Encephalitis, Viral
1
1998
45
0.030
 Why?
Haptoglobins
1
2018
71
0.030
 Why?
Drug Compounding
1
2018
107
0.030
 Why?
Protein Precursors
1
2018
136
0.030
 Why?
Immunologic Techniques
2
1994
38
0.030
 Why?
Celiac Disease
1
2021
311
0.030
 Why?
Glucosides
1
2017
56
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Botswana
1
2017
11
0.030
 Why?
Cell Transformation, Neoplastic
5
1977
337
0.030
 Why?
International Cooperation
1
2018
197
0.030
 Why?
Health Surveys
1
2019
520
0.030
 Why?
Internationality
1
2018
156
0.030
 Why?
Chemotaxis
1
2017
122
0.030
 Why?
Zimbabwe
1
2017
76
0.030
 Why?
Zambia
1
2017
58
0.030
 Why?
Bisoprolol
1
1996
2
0.030
 Why?
Graft Rejection
1
2000
521
0.030
 Why?
Antigens, Bacterial
1
2017
126
0.030
 Why?
Tanzania
1
2017
72
0.030
 Why?
Plasma
1
2018
223
0.030
 Why?
Patient Safety
1
2020
356
0.030
 Why?
Propanolamines
1
1996
40
0.030
 Why?
Cerebrospinal Fluid
2
1993
88
0.030
 Why?
Recovery of Function
1
2021
716
0.030
 Why?
Acute Disease
2
2011
1036
0.030
 Why?
Sinusitis
1
1999
227
0.030
 Why?
Leukemia, Lymphoid
2
1986
27
0.030
 Why?
Immune Tolerance
4
1998
385
0.030
 Why?
Biomarkers
2
2018
4302
0.030
 Why?
False Negative Reactions
1
1996
61
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
False Positive Reactions
1
1996
123
0.030
 Why?
Amniocentesis
2
1991
20
0.030
 Why?
Depressive Disorder
1
1998
374
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2015
46
0.030
 Why?
Analysis of Variance
2
2011
1300
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Half-Life
2
1992
155
0.030
 Why?
Adrenergic beta-Antagonists
1
1996
252
0.030
 Why?
Cross-Sectional Studies
4
2011
5925
0.030
 Why?
Chi-Square Distribution
2
2013
528
0.030
 Why?
Nausea
1
2015
112
0.030
 Why?
Vomiting
1
2015
131
0.030
 Why?
Area Under Curve
1
2015
332
0.030
 Why?
Bromodeoxyuridine
2
2007
77
0.030
 Why?
Fingolimod Hydrochloride
1
2015
40
0.030
 Why?
Disease Susceptibility
1
1996
344
0.030
 Why?
Gene Regulatory Networks
1
2017
318
0.030
 Why?
Product Surveillance, Postmarketing
1
2015
74
0.030
 Why?
Breast Feeding
1
2018
447
0.030
 Why?
Belgium
1
2014
11
0.030
 Why?
Neutropenia
1
2015
154
0.030
 Why?
Headache
1
2015
151
0.030
 Why?
Vaccines, Virus-Like Particle
1
2014
5
0.030
 Why?
HLA-A2 Antigen
1
2014
36
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Rubella
1
1974
23
0.030
 Why?
Culture Media
2
1984
161
0.030
 Why?
Immunoblotting
1
1994
295
0.030
 Why?
Probability
2
2005
308
0.030
 Why?
Tetanus Toxoid
1
1994
34
0.030
 Why?
Drugs, Investigational
1
2014
31
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
1994
29
0.030
 Why?
Bacterial Proteins
1
2000
968
0.030
 Why?
Statistics, Nonparametric
2
2004
428
0.020
 Why?
Seroepidemiologic Studies
1
2014
171
0.020
 Why?
Anemia
1
2015
191
0.020
 Why?
Phenotype
1
2002
3170
0.020
 Why?
Thrombocytopenia
1
2015
204
0.020
 Why?
Developed Countries
1
2013
38
0.020
 Why?
Haplorhini
8
1974
52
0.020
 Why?
Mortality
1
2015
381
0.020
 Why?
Drug Tolerance
1
1992
99
0.020
 Why?
Human papillomavirus 6
1
2011
2
0.020
 Why?
Phylogeny
2
2006
917
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Mycoplasma Infections
1
1991
17
0.020
 Why?
Skin
2
1989
754
0.020
 Why?
Genetics, Microbial
3
1971
10
0.020
 Why?
Arthritis, Rheumatoid
1
2021
1180
0.020
 Why?
Safety
1
1994
358
0.020
 Why?
Genitalia, Female
1
2012
42
0.020
 Why?
gamma-Globulins
1
1991
14
0.020
 Why?
Antibodies, Heterophile
1
1991
12
0.020
 Why?
Epstein-Barr Virus Nuclear Antigens
1
1991
12
0.020
 Why?
Adrenal Cortex Hormones
1
2015
484
0.020
 Why?
Absenteeism
1
2012
52
0.020
 Why?
Adenoviruses, Human
1
1991
26
0.020
 Why?
Metabolomics
1
2017
733
0.020
 Why?
Hospitals, University
1
1991
176
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Bodily Secretions
1
2010
2
0.020
 Why?
North America
1
2012
304
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
Tritium
7
1974
67
0.020
 Why?
Diagnosis, Differential
3
2009
1512
0.020
 Why?
Inflammation
2
2017
2884
0.020
 Why?
Europe
1
2012
421
0.020
 Why?
Early Detection of Cancer
1
2016
486
0.020
 Why?
Chlamydia Infections
1
1991
79
0.020
 Why?
DNA
4
1988
1437
0.020
 Why?
Schwann Cells
1
1990
33
0.020
 Why?
Antigens
2
1970
348
0.020
 Why?
Bacterial Infections
2
2001
247
0.020
 Why?
Cell Proliferation
1
2018
2514
0.020
 Why?
Rhinovirus
1
1990
60
0.020
 Why?
Antigens, Surface
2
1987
155
0.020
 Why?
Serotyping
2
1988
31
0.020
 Why?
Health Planning Guidelines
1
2010
24
0.020
 Why?
Self Administration
1
2010
122
0.020
 Why?
Gene Expression Profiling
1
2017
1777
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
883
0.020
 Why?
Hepatitis B Antibodies
1
2009
6
0.020
 Why?
Gestational Age
2
1989
990
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
In Situ Hybridization
2
2001
318
0.020
 Why?
Contraceptive Devices, Male
1
1989
1
0.020
 Why?
Spermatocidal Agents
1
1989
6
0.020
 Why?
Subacute Sclerosing Panencephalitis
1
1989
6
0.020
 Why?
Ribonucleosides
1
1989
7
0.020
 Why?
Reference Values
1
2011
798
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
655
0.020
 Why?
Immunohistochemistry
1
1993
1723
0.020
 Why?
Physical Examination
1
2010
244
0.020
 Why?
Thymidine
4
1980
60
0.020
 Why?
RNA, Antisense
1
1988
18
0.020
 Why?
Reference Standards
1
2009
177
0.020
 Why?
Nasal Mucosa
1
2009
112
0.020
 Why?
Virus Cultivation
4
1984
31
0.020
 Why?
Astrocytes
1
1990
228
0.020
 Why?
Reoviridae
1
1988
38
0.020
 Why?
Measles
1
1989
46
0.020
 Why?
Mammalian orthoreovirus 3
1
1988
38
0.020
 Why?
Hepatitis
1
1988
43
0.020
 Why?
Disease Progression
1
2016
2865
0.020
 Why?
DNA, Recombinant
1
1988
48
0.020
 Why?
Reoviridae Infections
1
1988
54
0.020
 Why?
Cancer Vaccines
1
2009
163
0.020
 Why?
Neoplasms, Experimental
1
1969
167
0.020
 Why?
Fetus
1
1992
804
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1988
157
0.020
 Why?
Health Services Needs and Demand
1
2010
280
0.020
 Why?
Cytopathogenic Effect, Viral
2
1982
16
0.020
 Why?
Microscopy, Electron
3
2001
414
0.020
 Why?
Body Fluids
1
1987
71
0.020
 Why?
Australia
1
2008
291
0.020
 Why?
Noma
1
1986
2
0.020
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
1
2006
13
0.020
 Why?
Biliary Atresia
1
1988
158
0.020
 Why?
Apoptosis
1
2015
2444
0.020
 Why?
Xenodiagnosis
1
2006
2
0.020
 Why?
Telomere
1
2010
287
0.020
 Why?
Valine
1
2007
83
0.020
 Why?
Gastrointestinal Hemorrhage
1
1988
138
0.020
 Why?
Embryo, Mammalian
3
1973
234
0.010
 Why?
Interleukin-4
2
1998
207
0.010
 Why?
Amino Acid Substitution
1
2007
302
0.010
 Why?
Kidney
9
1975
1497
0.010
 Why?
RNA, Ribosomal
1
2006
168
0.010
 Why?
Statistics as Topic
1
2006
283
0.010
 Why?
Reagent Kits, Diagnostic
1
1985
33
0.010
 Why?
Ketones
1
1986
50
0.010
 Why?
Gene Amplification
1
2006
118
0.010
 Why?
Nectins
1
2005
7
0.010
 Why?
Anti-Bacterial Agents
2
1999
1925
0.010
 Why?
Residence Characteristics
1
2008
375
0.010
 Why?
Lymphoproliferative Disorders
1
1985
59
0.010
 Why?
Mass Screening
1
2014
1361
0.010
 Why?
Factor Analysis, Statistical
1
2006
292
0.010
 Why?
Carbon Isotopes
5
1973
143
0.010
 Why?
California
1
2006
473
0.010
 Why?
Toll-Like Receptor 2
1
2005
125
0.010
 Why?
Chromosomes, Human
1
1984
44
0.010
 Why?
Streptococcus pneumoniae
1
2006
186
0.010
 Why?
Cytotoxicity, Immunologic
1
1985
224
0.010
 Why?
Hexuronic Acids
1
1984
29
0.010
 Why?
Glucuronic Acid
1
1984
30
0.010
 Why?
Toll-Like Receptors
1
2005
193
0.010
 Why?
Intensive Care Units, Neonatal
1
1988
293
0.010
 Why?
Freezing
1
1984
83
0.010
 Why?
Alginates
1
1984
60
0.010
 Why?
Polyethylene Glycols
1
1989
649
0.010
 Why?
Filtration
1
1984
68
0.010
 Why?
Culture Techniques
4
1973
66
0.010
 Why?
Bone Marrow Cells
1
1984
322
0.010
 Why?
RNA, Small Interfering
1
2005
638
0.010
 Why?
Fetal Blood
1
1985
327
0.010
 Why?
Stomatitis, Herpetic
1
1982
5
0.010
 Why?
Socioeconomic Factors
1
2007
1327
0.010
 Why?
Phosphonoacetic Acid
1
1982
10
0.010
 Why?
Up-Regulation
1
2005
848
0.010
 Why?
Agammaglobulinemia
1
1982
36
0.010
 Why?
NF-kappa B
1
2005
667
0.010
 Why?
Isoelectric Focusing
1
2001
30
0.010
 Why?
Prognosis
1
2010
4330
0.010
 Why?
Ulnar Nerve
1
2001
17
0.010
 Why?
Rural Population
1
2006
661
0.010
 Why?
Interleukin-6
1
2005
780
0.010
 Why?
Temperature
1
1984
633
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2001
331
0.010
 Why?
Cell Survival
1
1984
1104
0.010
 Why?
Brain
1
1993
2969
0.010
 Why?
Administration, Oral
2
1997
867
0.010
 Why?
Phytohemagglutinins
1
1980
29
0.010
 Why?
Serum Albumin
1
2001
147
0.010
 Why?
Disease Models, Animal
1
1991
4568
0.010
 Why?
Neuroglia
1
2001
174
0.010
 Why?
Phagocytosis
1
1982
296
0.010
 Why?
Ribosomes
1
2001
193
0.010
 Why?
Air Microbiology
1
1980
37
0.010
 Why?
Cell Communication
1
1982
327
0.010
 Why?
Leukocytes
1
1981
296
0.010
 Why?
Ambulatory Care
1
2004
610
0.010
 Why?
Nasal Decongestants
1
1999
9
0.010
 Why?
Immunity, Maternally-Acquired
1
1979
19
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
38
0.010
 Why?
Immunoglobulins
1
1979
163
0.010
 Why?
Mitogens
1
1978
55
0.010
 Why?
Lectins
1
1978
44
0.010
 Why?
Steroids
1
1999
160
0.010
 Why?
Rabbits
1
1979
653
0.010
 Why?
Th2 Cells
1
1998
175
0.010
 Why?
Amanitins
1
1977
4
0.010
 Why?
Cross Infection
1
1980
260
0.010
 Why?
Centrifugation, Density Gradient
3
1971
36
0.010
 Why?
Bronchopulmonary Dysplasia
2
1993
420
0.010
 Why?
Antigen-Antibody Complex
1
1997
69
0.010
 Why?
Interleukin-10
1
1998
311
0.010
 Why?
Combined Modality Therapy
1
1999
1271
0.010
 Why?
Erythrocytes
1
1982
749
0.010
 Why?
Adenoviridae Infections
1
1975
20
0.010
 Why?
Evidence-Based Medicine
1
1999
740
0.010
 Why?
Indicator Dilution Techniques
1
1994
12
0.010
 Why?
Uridine
2
1973
30
0.010
 Why?
Patient Selection
1
1999
739
0.010
 Why?
Centrifugation, Zonal
2
1971
2
0.010
 Why?
Abortion, Therapeutic
1
1974
3
0.010
 Why?
Rubella virus
1
1974
7
0.010
 Why?
Cesium
2
1971
20
0.010
 Why?
Heart Defects, Congenital
2
1993
910
0.010
 Why?
Molecular Biology
2
1971
58
0.010
 Why?
Sucrose
2
1971
114
0.010
 Why?
Chlorides
2
1971
138
0.010
 Why?
Complement Fixation Tests
2
1984
5
0.010
 Why?
Hemagglutination Tests
1
1991
7
0.010
 Why?
Pulmonary Fibrosis
1
1975
395
0.010
 Why?
Genes
1
1971
228
0.010
 Why?
Stress, Psychological
1
1998
1151
0.000
 Why?
Population Surveillance
1
1993
484
0.000
 Why?
Nonoxynol
1
1989
4
0.000
 Why?
Latex
1
1989
9
0.000
 Why?
Kidney Transplantation
1
1975
712
0.000
 Why?
Suspensions
1
1987
28
0.000
 Why?
Ribonucleases
1
1987
48
0.000
 Why?
Chloroquine
1
1987
54
0.000
 Why?
Deltaretrovirus
1
1986
12
0.000
 Why?
Binding, Competitive
1
1985
185
0.000
 Why?
Leukocyte Count
1
1985
318
0.000
 Why?
Mitosis
1
1985
193
0.000
 Why?
Histocompatibility Antigens Class II
1
1985
364
0.000
 Why?
Serologic Tests
1
1983
54
0.000
 Why?
Histocompatibility Antigens
2
1974
102
0.000
 Why?
Infusions, Parenteral
1
1982
48
0.000
 Why?
Leukemia
1
1983
246
0.000
 Why?
Hospital Bed Capacity, 300 to 499
1
1980
3
0.000
 Why?
Air Movements
1
1980
9
0.000
 Why?
Hospital Units
1
1980
32
0.000
 Why?
Boston
1
1980
93
0.000
 Why?
Liver
1
1988
1899
0.000
 Why?
Communicable Disease Control
1
1980
86
0.000
 Why?
Methods
1
1978
68
0.000
 Why?
p-Fluorophenylalanine
1
1976
2
0.000
 Why?
Cycloheximide
1
1976
42
0.000
 Why?
Hospitals, Pediatric
1
1980
558
0.000
 Why?
Inclusion Bodies, Viral
1
1975
3
0.000
 Why?
Cytoplasm
1
1976
254
0.000
 Why?
Cadaver
1
1975
311
0.000
 Why?
Transplantation, Homologous
1
1975
419
0.000
 Why?
Genetic Code
1
1971
24
0.000
 Why?
Nucleic Acid Denaturation
1
1971
32
0.000
 Why?
Chymotrypsin
1
1971
23
0.000
 Why?
Platinum
1
1971
48
0.000
 Why?
Molecular Weight
1
1971
312
0.000
 Why?
Carbon
1
1971
176
0.000
 Why?
DNA Replication
1
1971
249
0.000
 Why?
Hot Temperature
1
1971
396
0.000
 Why?
Lung
1
1975
4116
0.000
 Why?
Levin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (855) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)